About

Our Science

Our Programs

Careers

Investors & Media

Stockholder Tools

Global - Contact

Investor Contact

SEC Filing

SEC Filing Details

Document Details

Form
3
Filing Date
Jul 18, 2018
Document Date
Jul 18, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Constellation Pharmaceuticals
Issuer
CONSTELLATION PHARMACEUTICALS INC
Filer
Cormorant Asset Management, LLC